Ralph Zahn joined BIOCRATES in October 2010 as chief technology officer for the further development of the product pipeline and the affiliated technical and scientific assignments. He holds a PhD in natural science and has a wealth of experience in the field of biotech. After he graduated from biology, he worked as research associate and earned the doctors degree in 1994 at the Max-Planck-Institute for Biochemistry in Munich. At the Cambridge University he obtained a post-graduate doctor degree. He habilitated 2001 at the Institute for Molecular Biology and Biophysics at the Eidgenössischen Technischen Hochschule in Zurich. During his career, he was managing director at BioSafety GmbH and founder and CEO of allprion AG.
NMR structure of the bovine prion protein, NMR structures of three single-residue variants of the human prion protein, metabolomic Buiomarker Research, Molecular Biology and Biophysics